PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote “Light for PD” Clinical Trial
SALT LAKE CITY, UT, UNITED STATES, November 6, 2025 /EINPresswire.com/ -- PhotoPharmics, a clinical-stage medical device company pioneering Photo Neuromodulation for neurodegenerative disease, today announced it has surpassed its enrollment target with …